Subject
Health Policy,Pharmacology, Toxicology and Pharmaceutics (miscellaneous),Economics, Econometrics and Finance (miscellaneous)
Reference36 articles.
1. Global, regional, and national death, and disability-adjusted life-years (DALYS) for cardiovascular disease in 2017 and trends and risk analysis from 1990 to 2017 using the global burden of disease study and implications for prevention;Li;Front Public Health,2021
2. ACC/AHA lipid guidelines: personalized care to prevent cardiovascular disease;Reiter-Brennan;Cleve Clin J Med,2020
3. 2019 vs. 2016 ESC/EAS statin guidelines for primary prevention of atherosclerotic cardiovascular disease;Mortensen;Eur Heart J,2020
4. Associations between statins and adverse events in primary prevention of cardiovascular disease: systematic review with pairwise, network, and dose-response meta-analyses;Cai;BMJ,2021
5. Statin use for the primary prevention of cardiovascular disease in adults: updated evidence report and systematic review for the US Preventive Services Task Force;Chou;JAMA,2022